USA Inc is vastly exceeding expectations. First-quarter earnings reported as of last Friday had beaten analysts’ forecasts by a mammoth 30%; usually “earnings beats” are about 3%-6%, says Bob Pisani for CNBC. The unprecedented uncertainty triggered by the pandemic caused many blue-chip firms to withdraw their guidance last year. That prompted the analysts who study these firms to make very conservative forecasts for the earnings outlook, which were widely thought to be too pessimistic. Most people expected this quarter’s earnings to be good, “but this is really good”.
US stockmarket valuations are historically high on a cyclically adjusted price/earnings ratio (Cape) of 34.6, according to Mebane Faber of Cambria Investment Management. Strong earnings are one way of bringing those valuations down to a more reasonable level. Bank earnings have been especially impressive, says The Economist. JPMorgan Chase reported record revenue in the first three months of the year. Profits have tripled in a year at Citigroup and doubled at Bank of America. For the first time since 2008 banks are reporting returns on equity above 20%. They have profited from the first quarter-market frenzy, which saw massive trading by ordinary retail investors and frenetic activity on the mergers front. Goldman Sachs enjoyed a 40% yearly jump in its advisory fees.
Consumer-facing and bank stocks have delivered “stellar” earnings, but their stocks have not enjoyed a big boost, says Jon Sindreu in The Wall Street Journal. The KBW Bank index actually fell last week. Investors are starting to fret that the cheap stocks they loaded up on to benefit from economic reopening are the most vulnerable to rising prices. They are now buying “quality” – firms with low debt and cash reserves – instead.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
What will the unravelling of US-China trade mean for the economy?What will a US-China decoupling mean for the global economy?
-
Scottish Mortgage: why we’re turning to private companies and China for exceptional returnsWhen it comes to delivering growth, Scottish Mortgage will stop at no end in its hunt for exceptional long-term returns - this includes China, unicorn companies and sectors such as space exploration
-
Two ways to tap into monopoly profits from airportsMost investors can’t get their hands on airports. Here are two ways you can
-
Fat profits: should you invest in weight-loss drugs?The latest weight-loss treatments could transform public health and the world economy. Should you invest?
-
How investors could profit from Ramsden Holdings' four-part growth strategyRamsdens Holdings offers a diversified set of financial and retail services and a juicy yield, says Dr Michael Tubbs
-
How to invest in the booming insurance marketThe insurance sector is experiencing rapid growth after years of stagnation. Smart investors should buy in now, says Rupert Hargreaves
-
Out of America's shadow: Why Trump's tariff chaos may be good for non-US stocksOpinion Upending global investment and trade could benefit other countries at the expense of the US market, says Cris Sholto Heaton
-
BP's 'long, painful decline' – and why next year could be even tougherOpinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global marketsOpinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
-
Klarna postpones US IPO as Trump's tariffs rattle marketsBuy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
